These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. [Therapy of hepatic encephalopathy]. Nolte W; Ramadori G Dtsch Med Wochenschr; 1996 May; 121(21):699-701. PubMed ID: 8646977 [No Abstract] [Full Text] [Related]
46. [Therapy of hepatic encephalopathy. Changes in the cerebrospinal fluid concentration of catecholamine neurotransmitters, ammonia and amino acids in the course of an infusion treatment with branched-chain amino acids]. Rössle M; Herz R; Lehmann G; Luft M; Gerok W Infusionsther Klin Ernahr; 1982 Oct; 9(5):256-8. PubMed ID: 7141673 [TBL] [Abstract][Full Text] [Related]
47. [Treatment of hepatic encephalopathy with oral branched-chain amino acids: I. Acute hepatic encephalopathy]. Caballería Rovira E; Arago López JV; Masso Ubeda RM; Vidal Clemente JL; Sanchís Closa A Rev Esp Enferm Apar Dig; 1987 Aug; 72(2):116-22. PubMed ID: 3659529 [No Abstract] [Full Text] [Related]
48. [Liver, protein metabolism and branched-chain amino acids]. Bernardi R Clin Ter; 1981 Dec; 99(6):653-75. PubMed ID: 7037278 [No Abstract] [Full Text] [Related]
49. Branched-chain amino acids for the treatment of hepatic encephalopathy. Med Lett Drugs Ther; 1983 Jul; 25(640):72. PubMed ID: 6865852 [No Abstract] [Full Text] [Related]
50. Nutritional therapy in patients with liver cirrhosis. Kondrup J; Nielsen K; Hamberg O Eur J Clin Nutr; 1992 Apr; 46(4):239-46. PubMed ID: 1600920 [No Abstract] [Full Text] [Related]
51. Influence of an orally administered protein mixture enriched in branched chain amino acids on the chronic hepatic encephalopathy (CHE) of patients with liver cirrhosis. Schäfer K; Winther MB; Ukida M; Leweling H; Reiter HJ; Bode JC Z Gastroenterol; 1981 Jul; 19(7):356-62. PubMed ID: 7293293 [TBL] [Abstract][Full Text] [Related]
52. Effect of branched chain amino acid-enriched amino acid solution on normalization of plasma amino acids in hepatic encephalopathy. Liaw KY; Chang CN; Wei TC; Lin JK Taiwan Yi Xue Hui Za Zhi; 1985 Mar; 84(3):331-8. PubMed ID: 3860605 [No Abstract] [Full Text] [Related]
53. Hepatic Encephalopathy. Blei AT; Córdoba J; Am J Gastroenterol; 2001 Jul; 96(7):1968-76. PubMed ID: 11467622 [TBL] [Abstract][Full Text] [Related]
54. [Treatment of hepatic encephalopathy with branched-chain amino acids (BCAA) by oral route: II. Chronic hepatic encephalopathy]. Caballería Rovira E; Arago López JV; Masso Ubeda RM; Vidal Clemente JL; Sanchís Closa A Rev Esp Enferm Apar Dig; 1987 Sep; 72(3):201-5. PubMed ID: 3685578 [No Abstract] [Full Text] [Related]
55. Therapy of portal-systemic encephalopathy: the practical and the promising. Weber FL Gastroenterology; 1981 Jul; 81(1):174-7. PubMed ID: 7239116 [No Abstract] [Full Text] [Related]
56. The role of nutrition in hepatic encephalopathy. Schulz GJ; Campos AC; Coelho JC Curr Opin Clin Nutr Metab Care; 2008 May; 11(3):275-80. PubMed ID: 18403924 [TBL] [Abstract][Full Text] [Related]
58. Motor vehicle accidents: how should cirrhotic patients be managed? Kawaguchi T; Taniguchi E; Sata M World J Gastroenterol; 2012 Jun; 18(21):2597-9. PubMed ID: 22690067 [TBL] [Abstract][Full Text] [Related]
59. Effect of vegetable and animal protein diets in chronic hepatic encephalopathy. Greenberger NJ; Carley J; Schenker S; Bettinger I; Stamnes C; Beyer P Am J Dig Dis; 1977 Oct; 22(10):845-55. PubMed ID: 335882 [No Abstract] [Full Text] [Related]
60. Severe recurrent hepatic encephalopathy that responded to oral branched chain amino acids. Chalasani N; Gitlin N Am J Gastroenterol; 1996 Jun; 91(6):1266-8. PubMed ID: 8651189 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]